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Abstract The effect of prolyl bond isomers on the substrate
recognition capabilities of various endoproteases may be
investigated in a reaction where both cis/trans isomers co-exist.
Here we address the question of whether enzyme reactions at the
side chain of an amino acid preceding proline proceed through an
isomer specific pathway. The proline-directed p42 mitogen-
activated protein kinase (ERK2) was used to phosphorylate the
serine side chain in Pro-Arg-Ser-Pro-Phe-4-nitroanilide under
conditions where different amounts of cis prolyl isomer of the
substrate were present. Initial phosphorylation rates were
calculated ranging between zero at 100% cis isomer and around
60 pM/min at the equilibrium content of 83.5% trans isomer. In
the presence of the peptidyl-prolyl cis/trans isomerase human
hFKBP12 (500 nM), cis/trans isomerization proceeds rapidly,
permitting the maximal phosphorylation rate to be observed in
the dead time of the experiment. Results show that correct
signature sequences are not sufficient to render potential
substrates reactive to proline-directed enzymatic phosphoryla-
tions, but that the conformational state of the peptide bond
following serine (threonine) is a critical determinant. Therefore,
catalysis by peptidyl-prolyl cis/trans isomerases may add a new
level of control to intracellular protein phosphorylations. ß 2000
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
The primary substrate speci¢city determinant for a number
of protein kinases capable of phosphorylating serine (threo-
nine) residues is a proline following the phosphorylation site.
Proline-directed protein kinases include the multigene families
of cyclin-dependent protein kinases (Cdks) and mitogen-acti-
vated protein (MAP) kinases [1,2]. Cdks play an important
role in control of the cell cycle. A large variety of mitogens
can stimulate the activation of MAP kinases by phosphoryla-
tion on tyrosine and threonine residues causing signal trans-
duction from the cell surface to the nucleus [3,4]. Because a
proline residue represents the ultimate cause of serine (threo-
nine) side chain phosphorylation by MAP kinases, analysis of
proline-mediated substrate properties may contribute to the
identi¢cation of recognition determinants associated with pro-
ductive enzyme/substrate interactions.
Unlike other peptide bonds, peptidyl-prolyl bonds form cis
and trans isomers of comparable thermodynamic stability.
Thus, slowly interconverting prolyl isomers of native proteins
[5^9], unfolded or partially folded polypeptides [10] and oli-
gopeptides [11] o¡er alternatives for proteins to bind. Conse-
quently, cis/trans isomer speci¢c reactions have already been
identi¢ed in protein^ligand and enzyme^substrate interactions
[12^15] as well as in the refolding of denatured proteins [16].
Between enzymes, endoproteases often exhibit speci¢city for
discriminating among isomeric substrates even if the isomeric
bond is remote from the scissile linkage [17]. The discrimina-
tion factor among the cis/trans isomers of proline-containing
substrates depends on the position of proline relative to the
scissile bond. This factor tends to be high, in favor of the
trans isomer. Obviously both critical bonds are intrinsic parts
of the backbone: the peptide bond cleaved by the protease
and the isomeric bond. Conversely, in proline-directed
Ser(Thr) phosphorylation, the reaction center is a side chain
hydroxyl group. It may be suggested that this arrangement
allows single bond rotations to position the side chain cor-
rectly within the active site of the kinase regardless of the
adjacent backbone conformation.
The recently determined crystal structure of a complex con-
sisting of phospho-CDK2/cyclin A3/substrate in the presence
of an inactive ATP analogue has given an impression of the
substrate arrangement in the active site of a proline-directed
kinase. The trans conformation of the prolyl bond in the
bound peptide HHASPRK [18] indicates conformational spe-
ci¢city of substrate binding but does not provide conclusive
evidence about conformational speci¢city of the productive
pathway.
The aim of our study was to investigate, by a direct meth-
od, to which extend the proline-directed p42 MAP kinase
ERK2 is able to bind productively a Ser-Pro-containing sub-
strate in both isomeric states. Results may allow prediction of
the in£uence of peptidyl-prolyl cis/trans isomerases on the
time-course of the ERK2-mediated phosphorylations. An ex-
perimental approach to verify predictions has been developed
with the human hFKBP12 as this PPIase is active toward the
ERK2 substrate utilized.
2. Materials and methods
2.1. Materials
Recombinant murine p42 MAP kinase (ERK2) produced in Esche-
richia coli was purchased from New England BioLabs Inc.; recombi-
nant eglin C was from Sigma (Deisenhofen, Germany); bovine pan-
creas K-chymotrypsin was from Boehringer (Mannheim, Germany);
inhibitor FK506 was from Alfons Lawen (Monash University, Mel-
bourne, Australia); [Q-33P]ATP (3000 Ci/mM) was from ICN. Re-
combinant human hFKBP12 was kindly provided by Dr. J.U. Rah-
feld (University Halle). Peptides, as Pro-Arg-Ser-Pro-Phe-NHNp and
its phosphorylated analogue were synthesized according to [19].
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2.2. Preparation of cis Pro-Arg-Ser-Pro-Phe-NHNp
Pure cis isomer was prepared using isomer speci¢c proteolysis by
K-chymotrypsin (170 WM) applied to an equilibrated mixture of cis
and trans conformer of Pro-Arg-Ser-Pro-Phe-NHNp (1.7 mM). After
a reaction time of 1 min, the trans conformer was completely hydro-
lyzed at the 4-nitroanilide bond, and chymotrypsin was rapidly inac-
tivated by adding a 1.4-fold molar excess of eglin C from a 1.16 mM
stock solution in 0.5 mM HCl. The remaining cis conformer of Pro-
Arg-Ser-Pro-Phe-NHNp is stable only transiently. Isomerization oc-
curs according to a ¢rst-order reaction until the cis/trans equilibrium
is reached. In some experiments, hFKBP12 (0.5 WM) was added to
accelerate equilibration. FK506 (20 WM) was used as speci¢c inhibitor
of hFKBP12. All reactions were performed at 0‡C.
For determination of the rate constant of cis/trans isomerization,
aliquots were taken after di¡erent times and the cis content was de-
termined by isomer speci¢c proteolysis [20].
2.3. Kinase assay
During the re-equilibration of the cis peptide, aliquots (5 Wl) of the
mixture were subjected to p42 MAP kinase (5 Wl, 10 000 U/ml) in the
presence of [Q-33P]ATP (15 WCi). After 3 min, phosphorylation was
stopped by adding tri£uoroacetic acid (TFA). To ensure initial ki-
netics, phosphorylation was followed only 1% toward completion.
All reactions were carried out at 0‡C.
Aliquots were separated by thin layer chromatography (TLC) using
silica gel 60F254 from Merck with a butanol/water/acetic acid/ethanol
(2:4:1:1) mixture, and submitted to autoradiography with an intensi-
fying screen. The signals were quanti¢ed using a Fuji BAS reader. The
phosphorylated substrate Pro-Arg-Ser(OPO3H2)-Pro-Phe-NHNp was
used as TLC reference.
3. Results
3.1. Initial enzymatic phosphorylation rates in dependence of
the re-equilibration time
In order to address the issue of how the MAP kinase ERK2
recognizes a certain prolyl bond isomer in polypeptide chains,
our ¢rst approach utilized a oligopeptide substrate containing
a Ser-Pro motif. Derived from the consensus sequence of
ERK2 sensitive phosphorylation sites, the short oligopeptide
Pro-Arg-Ser-Pro-Phe-NHNp proved to be very useful in
studying phosphorylation kinetics. This was re£ected in both
kcat (0.0066 min31) and Km (690 WM) at 0‡C which ensure a
speci¢city constant large enough for a detectable amount of
substrate phosphorylation after a short period of time of
ERK2 incubation.
In aqueous solution at pH 7.5, both prolyl isomers of the
oligopeptide co-exist with 16.5 þ 0.2% in the cis conformation
(Fig. 1). For evaluating cis/trans isomer speci¢city of ERK2,
the cis peptide in its conformationally pure state might be
prepared by isomer speci¢c proteolysis using K-chymotrypsin.
This method is based on the exclusive cleavage of the trans
pentapeptide-4-nitroanilide at the anilide bond in a fast reac-
tion. Subsequently, the protease was rapidly inactivated by
eglin C. The remaining cis isomer is transiently homogeneous
but re-equilibrates in a ¢rst-order rate process. To decrease
the cis/trans isomerization rate, all experiments were carried
out at 0‡C. At this temperature, the ¢rst-order rate constant
for the cis/trans isomerization of the peptide was
2.08 þ 0.08U1033 s31.
To ¢nd out whether the isomeric composition of the peptide
a¡ects the phosphorylation rate of ERK2, aliquots of the re-
equilibrating mixture were sampled over the period of the
isomerization time and incubated with ERK2, followed by
the analysis of phosphorylation products by TLC. When cis/
trans isomer speci¢city occurs, the concentration of the sub-
strate productively bound on ERK2 should depend on sam-
pling time. Keeping in mind the rate law for initial rates, a
constant magnitude for this parameter over sampling time
must be lacking. As shown in Fig. 1, the increase in initial
rates of the enzymatic phosphorylation correlated with the re-
equilibration time, indicating cis/trans isomer speci¢city. Si-
multaneously, the content of trans isomer increased from 0
to 83.5%. Curve ¢tting of the plot resulted in a ¢rst-order
rate constant of 1.95 þ 0.13U1033 s31 that ¢ts the ¢rst-order
rate constant measured directly for the cis/trans isomerization.
3.2. The e¡ects of the peptidyl-prolyl cis/trans isomerase
hFKBP12
From the above data, the dependence of the initial rate of
phosphorylation on the lag time following isomer speci¢c pro-
teolysis indicates a crucial role of prolyl bond isomerization
for ERK2 catalysis. In order to con¢rm the conformational
speci¢city of ERK2, the speci¢c acceleration of the Ser-Pro
cis/trans isomerization by hFKBP12 has been utilized. This
PPIase exhibits a speci¢city constant of kcat/Km = 29 mM31
s31 for the substrate peptide, permitting the application of
catalytical amounts of hFKBP12 (substrate/hFKBP12 ra-
tio = 560) to substantially increase the cis/trans isomerization
rate. Results are shown in Fig. 2. In the presence of
hFKBP12, initial phosphorylation rates are increased com-
pared to the PPIase-free control. Moreover, the rate of phos-
phorylation in the hFKBP12-containing mixture reaches the
level of the thermally equilibrated mixture. The e¡ect of
hFKBP12 is abolished by the hFKBP12 inhibitor FK506.
To test whether the kinase is directly in£uenced by hFKBP12,
we studied the phosphorylation of the equilibrated peptide in
presence and absence of the PPIase. The initial rates of the
enzymatic phosphorylation were comparable 63 þ 2 pM/min
respectively 64 þ 2 pM/min (the data shown are the mean of
Fig. 1. Initial phosphorylation rates in dependence of the lag time
that follows quenching of isomer speci¢c proteolysis of Pro-Arg-Ser-
Pro-Phe-NHNp (re-equilibration time) at 0‡C. During re-equilibra-
tion, aliquots of the mixture were subjected to p42 MAP kinase (0.1
WM) in the presence of [Q-33P]ATP (15 WCi). After 3 min incubation
time, phosphorylation was stopped by adding TFA. Phosphoryla-
tion mixtures were separated by TLC. Autoradiographies were
quanti¢ed using a Fuji BAS reader (closed circles: phosphorylation
rates). Cis contents were determined by isomer speci¢c proteolysis
in independent measurements (open squares: percentage of cis).
Each point represents the mean of three independent experiments.
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three independent experiments). Thus we exclude an e¡ect of
hFKBP12 on the kinase itself.
4. Discussion
The occurrence of cis and trans conformers of the peptidyl-
prolyl bond in unstructured polypeptides as well as in native
proteins raises a question concerning the biologically active
form of the molecule. Cis/trans isomer speci¢c conversions
have been found directly in protein folding, proteolysis and
protein/ligand interactions [8,12,13,21], all of which involve
backbone linkages in the reaction. The e¡ect of PPIase activ-
ity on the signal transduction of transmembrane receptors
provides indirect evidence for cis/trans isomer speci¢c process-
es [22,23].
The present paper describes a reliable method to evaluate
the cis/trans isomer speci¢city of proline-directed protein ki-
nases by measuring initial phosphorylation rates of oligopep-
tides in dependence of the lag time following a proteolytic
pulse. For p42 MAP kinase, K-chymotrypsin has been used
as a cis/trans isomer speci¢c protease in conjunction with a
Ser-Pro-Phe sequence segment forming a suitable kinase sub-
strate. At 0‡C, cis/trans isomerization of the substrate is slow
enough to ensure a su⁄cient number of data points for the
initial rate constants to calculate the rate constant of cis/trans
isomerization from phosphorylation measurement. The calcu-
lated constant ¢ts well to the rate constant determined by
direct monitoring of cis/trans isomerization rates.
Using this method, the initial phosphorylation rates in-
crease during the conformational re-equilibration of Pro-
Arg-Ser-Pro-Phe-NHNp, where a zero phosphorylation rate
occurs with the pure cis conformer. Phosphorylation increases
up to saturation level with the emergence of trans conformer
of the substrate. A constant initial phosphorylation rate
would be expected if the cis/trans isomer speci¢city of
ERK2 does not exist under the same conditions. This point
was investigated further in the experiment performed in the
presence of the PPIase hFKBP12. The ubiquitous FKBP12
represents just a single member of dozens of di¡erent PPIases
in cells [11]. This PPIase was used as an enzyme tool to cata-
lyze the conformational re-equilibration. Thus, the substrate
was allowed to re-equilibrate in the dead time of the experi-
ment (30 s) by catalyzing its cis/trans isomerization by
hFKBP12. A cis/trans isomer speci¢city of ERK2 could not
be seen under these conditions. Inhibition of hFKBP12 by
FK506 provides evidence for the required active PPIase for
the observed e¡ect on the initial rates of phosphorylation
(Fig. 2).
In conclusion, p42 MAP kinase-catalyzed phosphorylation
exhibits a pronounced speci¢city for substrates with a trans
prolyl bond adjacent to the reactive serine residue. This may
indicate that not only the primary sequence and the accessi-
bility of the phosphorylation site, but also the conformation
of Ser(Thr)-Pro bond is important for a substrate to be rec-
ognized by a proline-directed protein kinase. For phosphory-
lation of oligopeptides under steady state conditions in homo-
geneous solution, the presence of the inert cis isomer only
a¡ects the Km value. However, greater e¡ects may occur in
the phosphorylation of the conformationally homogeneous
Ser(Thr)-Pro moieties in proteins, and in kinetically coupled
processes where quasi-irreversibility is involved. To demon-
strate the conformational speci¢city of a protein kinase, we
used a peptide as model. Former experiments [20] using well-
de¢ned peptides already showed the isomer speci¢c proteoly-
sis of prolyl peptide bonds and revealed the folding helper
enzymes. We used a similar approach and therefore we sug-
gest that our data on isomer speci¢c phosphorylation on pep-
tides allow extension to other peptide sequences and proteins.
Regarding proteins, it has been shown by analysis of the
structure database that about 5% of Ser-Pro moieties in pro-
teins exist as cis prolyl bonds [24]. In both cases, complete
discrimination of an otherwise phosphorylatable moiety can
be suggested. Moreover, the results of this study provide the
¢rst hints that enzyme reactions at side chains of polypeptides
might be a¡ected by the backbone conformation adjacent to
the reactive site. Because peptidyl-prolyl cis/trans isomerases
of the cyclophilin and FKBP family have the potential to shift
half-times of cis/trans isomerizations into a millisecond time-
range [25], potential control of protein phosphorylation by cis/
trans isomer speci¢city of proline-directed protein kinases can
be speci¢cally abolished. Provided that protein phosphatases
are also able to discriminate prolyl bond isomers, the con-
certed action of these enzymes adds a completely new level
of complexity to the phosphorylation/dephosphorylation of
proteins.
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